Wegovy Shortage by State Tracker October 2026
GLP-1 medication shortages remain a burden on patients across all 50 states. We’re sharing up-to-date tracking on availability and alternatives.
Supply Snapshot
As of October 2026, availability for these drugs differs dramatically by:
- Product and dosage: Starting strengths are typically in better supply than higher strengths
- Where you live: Distribution networks favor major metro regions while smaller markets see more shortages
- Pharmacy type: Non-chain pharmacies occasionally access what chain pharmacies can’t get
By Strength
Initial Titration Strengths
Low-dose strengths are usually in better supply because:
- A smaller population remains on initial dosing long-term
- Drug makers focus production on initial supply to maintain new patient access
Target Strengths
Target dosing face more pressure because:
- The majority of users graduate to higher doses and stay there
- Production hasn’t caught up with growing demand
If You’re Affected
Right Now
- Phone before visiting — don’t visit any location without confirming that they have it
- Check several pharmacies — call at least 5 stores across different chains
- Get on a notification list — many pharmacies can alert you when your dose comes in
Extended Supply Issues
- Talk to your prescriber about alternative dosing — your prescriber could suggest an alternative approach
- Explore compounded alternatives — if the drug is on the FDA shortage list, custom formulations may be accessed
- Contact the drug maker — the manufacturers offer resources to locate medication
Monitoring Resources
Monitor these channels to keep current:
- The official FDA list — the authoritative source
- Novo Nordisk and Eli Lilly — supply updates directly from the companies
- Retail pharmacy apps — some show whether it’s in stock
- Support groups — fellow users post current stock findings
New data is added as conditions change.